In context
Palmitoyl tetrapeptide-7 was one component of an eye-cream complex studied in fibroblasts and a 12-week human cosmetic study. [1]
At a glance
- Type
- Topical cosmetic ingredient
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- The cream contained several active ingredients. The study cannot isolate this peptide's effect or justify transferring the result to another formulation.
How to interpret this evidence
The cream contained several active ingredients. The study cannot isolate this peptide's effect or justify transferring the result to another formulation. [1]
Safety and clinical context
Topical cosmetic research does not support injection or other systemic use. Safety and tolerability depend on the complete formulation and the person using it.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.